Itraconazol Ab

Itraconazole, the active ingredient in Itraconazol Ab, is an azole antifungal presented as an oral formulation for oral use. It treats a range of systemic and superficial fungal infections in adult patients. GNH USA supplies Itraconazol Ab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Itraconazole acts on fungal pathogens by inhibiting ergosterol synthesis, making it useful for several deep and superficial mycoses.

- Dermatophyte infections: effective for skin and nail infections caused by dermatophyte fungi. - Onychomycosis: improves cure rates in fungal nail disease. - Systemic candidiasis: treats invasive Candida infections. - Aspergillosis: used for chronic and invasive forms of Aspergillus infection. - Blastomycosis: helps eradicate Blastomyces dermatitidis. - Histoplasmosis: indicated for disseminated Histoplasma capsulatum infection.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Abdominal pain: cramping or discomfort. - Diarrhea: loose stools. - Elevated liver enzymes: mild hepatic enzyme rise. - Rash: mild skin irritation.

Serious or Rare Side Effects: - Hepatotoxicity: significant liver injury. - Congestive heart failure: fluid retention and reduced cardiac function. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Visual disturbances: blurred vision or photopsia. - Peripheral edema: swelling of extremities.

Before initiating therapy, consider patient‑specific factors and monitor appropriately.

- Liver function: assess baseline hepatic enzymes and monitor during treatment. - Cardiac status: avoid in patients with existing heart failure. - Drug interactions: review concomitant medications for CYP3A4 substrates. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Renal impairment: adjust dose if severe renal dysfunction is present. - Store below 25°C: keep in the original container, protect from moisture and light.

Itraconazole has a notable interaction profile that requires careful management.

Major Interactions (Avoid): - Rifampin: markedly reduces itraconazole exposure. - St. John’s wort: induces metabolism, lowering efficacy. - Certain antiarrhythmics (e.g., quinidine): may cause serious cardiac effects.

Moderate Interactions (Monitor Closely): - Statins (e.g., simvastatin): increased risk of myopathy. - Proton pump inhibitors: may decrease absorption. - Certain benzodiazepines: enhanced sedation. - Anticoagulants (e.g., warfarin): may alter INR values.